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Abstract
Lipases (triacylglycerol acylhydrolases, EC 3.1.1.3) function as significant biocat-
alysts in biotechnological applications. The fact that their mechanism, selectivity and
structure is well known make lipases a suitable candidate for studies of protein engineer-
ing and directed evolution. Using the merits of DNA shuffling method, directed evolution
and random mutagenesis,libraries of mutant lipases are constructed with improved fea-
tures and functionality of pre-existing ones, which in turn encourages the use of industrial
lipases in applications such as biosensors, pharmaceuticals, agrochemicals, bioremedia-
tion, etc. With increasing demand on lipase production for commercial use, it has thus
become crucial to identify and isolate novel and target-specific lipases, as well as opti-
mizing existing ones for acquisition of desired functionality. The aim of this study is to
generate mutant lipase libraries using directed evolution and to screen for a candidate bio-
catalyst. There are two lipases of interest, the mesophilic Aspergillus niger lipase (ANL)
and the thermophilic Bacillus thermocatenulatus lipase (BTL), which were shuffled in
order to obtain a mutant library that would have the desired features such as increased
thermostability, pH stability and a broader range of substrate specificity.
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O¨zet
Lipazlar (triasilgliserol asilhidrolaz EC 3.1.1.3), biyoteknolojik uygulamalarda etkili rol
oynayan biyokatalizo¨rlerdir. Mekanizmaları, sec¸icilikleri ve yapıları bilindig˘i ic¸in, pro-
tein mu¨hendislig˘i ve yo¨nlendirilmis¸ evrim metodlarına uygun adaylardır. DNA karma
metodu, yo¨nlendirilmis¸ evrim ve rastgele mutajenez tekniklerinin bir arada kullanılabilmesi,
istenilen o¨zelliklere sahip mutant lipaz ku¨tu¨phanelerinin olus¸turulabilmesine imkan tanımıs¸tır.
Bu durum, lipazlarin aynı zamanda biyosenso¨r, ilac¸, tarım endu¨strilerinde kullanılmasına
olanak sag˘lamıs¸tır. Lipazların ticari kullanımına kars¸ı artan talep sonucu yeni ve hedefe
o¨zgu¨n lipazların tanımlanması ve izole edilmesi kritik o¨nem tas¸ımaktadır. Bu tez, yo¨nlendirilmis¸
evrim teknig˘iyle mutant lipaz ku¨tu¨phanelerinin olus¸turulmasını hedef almakla beraber,
aday biyokatalizo¨rlerin analizini yapmayı amac¸lamaktadır. Bunun ic¸in, fungal ve mezofi-
lik bir lipaz olan Aspergillus niger lipazı (ANL) ile bakteriyel ve termofilik bir lipaz olan
Bacillus thermocatenulatus lipazı (BTL) DNA karma metodu ile karıtırılmıs¸tır. Rast-
gele mutajene olacak olan enzimlerin, termostabilite, pH stabilite ve su¨bstrat sec¸icilig˘inde
artı go¨stermesi ve endu¨striyel ve biyokteknolojik uygulamalarda o¨nemli bir lipaz olması
o¨ngo¨ru¨lmektedir. Elde edilen klonlarda, su¨bstrat sec¸icilig˘i deg˘is¸iklig˘i go¨ru¨lmemekle be-
raber, enzimlerin genel aktivitelerinde belirli deg˘is¸iklikler saptanmıs¸, ve bu o¨zellikler
yapısal boyutta tartıs¸ılmıs¸tır.
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1 Introduction
1 .1 Lipases
Lipases are metabolic enzymes which are involved in every domain of life. Animals,
plants and microorganisms are all producing various types of lipases. Lipases were dis-
covered by Eijkmann in 1900s. This discovery was simply the observation of several
bacteria that can produce and secrete lipases and the degradation of lipids via these pro-
duced enzymes. Microbial enzymes are one of the largest enzyme class due to the large
variety of known microbes and therefore lipases are one of the most studied enzyme class
as well. Since lipases have been studied sweepingly, their mechanism of action, selectiv-
ity and structure are already well known [1, 2].
Lipases (triacylglycerol acylhydrolases; EC 3.1.1.3) function as biocatalysts to hy-
drolyze triglycerides into glycerol and fatty acids on water-insoluble substrates [3].They
actively have a role on the digestion, transportation and processing of triglycerides. It is
well known fact that bacteria, yeast and fungi share a high potential on the production of
lipases. Since lipases which are produced from different types of microorganisms have
specific features in terms of substrate specificity, heat resistance thresholds and wide pH
range, these features make them efficient in terms of selectivity through many industrial
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applications such as biosensors, pharmaceuticals, cosmetics, agrochemicals, bioremedia-
tion etc. Lipases have been used on numerous studies, ranging from industrial production
and immobilization techniques, to the analysis of pure enzymes and their biocatalytical
features [4]. For instance, lipase-detergent compounds are used to clean surface fatty
residues and clogged drains [5].
As well as being lipolytic, lipases have the capability to perform esterification. This
combined feature enables them to be effective under wide substrate range [6]. With in-
creasing demand on lipase production for commercial use, it has become crucial to iden-
tify and isolate novel and target-specific lipases, as well as optimizing existing ones for
acquisition of desired functionality. Nowadays, this can be achieved by directed evolution
techniques, and it is heavily relied upon [7]. By means of directed evolution, it is aimed
to improve features and functionality of pre-existing lipases, both with time and cost ef-
ficiency. DNA shuffling is a widely used technique, serving as a fundamental method for
studies in directed evolution.
Since properties of lipases are mainly strain-dependent, the catalytic properties and
functional parameters are crucial for design and application procedures, including ther-
mostability, specificity, optimum pH and enantioselectivity. For instance, Aspergillus
niger lipase (ANL) is one of the significant biocatalysts used in industrial food process-
ing and production, utilized as food and detergent additive, as well as in cellulose acety-
lation [8]. ANL shows regio-selectivity on its first and third position, towards glycerol
binding site. Because of this, this lipase has proven to be safe for utilization in food and
pharmaceutical industry [9]. The thermoalkalophilic lipase, Bacillus thermocatenulatus
lipase 2 (BTL2), on the other hand, is an enantioselective biocatalyst which shows consid-
erably high resistance and stability at elevated temperatures and organic solvents, making
it a hub for industrial and biotechnological applications [10]. Quyen et.al, (2002) have
successfully produced the recombinant BTL lipase out of both Pichia pastoris and E.coli
and performed enzyme characterization [11].
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1 .2 Reaction
The hydrolysis of triacylglycerols to free fatty acids, diacylglycerols, monoacylglyc-
erols and glycerol is catalyzed by lipases. This breakdown reaction is an equilibrium
reaction, which can be disturbed by changing the concentration of substrates or products.
One of the reactants of hydrolysis reaction is water. Therefore, changing the hydrolytic
conditions of the hydrolysis causes a shift of the equilibrium [12].
Either by breaking as in hydrolysis or by forming as in esterification, lipases act on
carboxylic ester bonds. The acyl transfer reactions through esterification are also cat-
alyzed by lipases. Triacylglycerols are commonly their natural substrates, depending on
the chemical properties of the reactants and the amount of water in the medium [13].Un-
der low water conditions, a carboxyl/thiolester or amide can also be formed. An ester
group, serving as an acyl donor, can form an acyl-enzyme intermediate by either releas-
ing an acid, in this case acyl acceptor would be water, or by forming a new ester and in
that case acyl acceptor would be alcohol/thiol/amine. In addition, acidolysis, alcoholysis,
aminolysis and interesterification can be given as examples to transesterification.
1 .3 Mechanism
Although lipases catalyze many versatile reactions, the reaction mechanisms are dis-
tinctive. In all lipases, the catalytic machinery is conserved and it is composed of three
residues, which are serine, histidine and aspartate/glutamate [14]. Two residues (histidine
and aspartate/glutamate) are aligned in order to lower the pKa of the serine hydroxyl,
so that serine can carry out a nucleophilic attack on the ester bond. The acyl donor, the
substrate, interacts with the active site of the lipase, forming the enzyme-substrate (ES)
complex. The hydroxyl group of serine is activated by the histidine in the catalytic triad.
Serine carries out a nucleophilic attack on the carbonyl carbon of the substrate, so that
the first tetrahedral intermediate is formed. The main-chain amide groups of two residues
generate a hole and the negative charge on the oxyanion is stabilized. The aspartate or
glutamate stabilize the positive charge on the histidine. The tetrahedral intermediate is
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then decomposed into another intermediate which is determined by the first leaving group
of the substrate (an alcohol or an acyl enzyme intermediate). A second tetrahedral in-
termediate is formed right after the formation of the acyl enzyme intermediate. Newly
formed intermediate corresponds to the highest energy barrier in the reaction. In order to
yield the deacylated-free form of the enzyme and the hydrolysis of the second substrate,
an acid, this intermediate is also collapsed. A proton is transfered from the substrate to
histidine during the deacylation step.
Scheme 1: Mechanism of hydrolysis by lipases. During Step A, His residue acts as a
general base and removes a proton from the active site of Ser. In Step B, an acyl-enzyme
intermediate is formed, followed by the deacetylation (Step C). With a nucleophile
attacking the acetylated enzyme, the catalytic site is regenerated and a long-chain fatty
acid is formed as a product (Step D). [15]
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1 .4 Selectivity
Lipase selectivity towards Triacylglycerols (TAGs) is generally categorized as regio-
selectivity, stereo-selectivity and substrate selectivity [16,17]. Regio-selectivity is related
to the position of the ester bond in TAG, whereas stereo-selectivity is related to the chiral
center. Substrate selectivity is related to the type and chain-length.
1 .4.1 Substrate Selectivity
Lipases show selectivity regarding to the type and the chain-length of the acyl groups in
their substrates. They can differ in terms of certain fatty acids or groups of fatty acids. For
instance, porcine is a lipase with specificity to cis-2 over cis-7 octadecenoyl moiety [2].
Moreover, the lipases most preferred substrate is primary alcohols and the least preferred
is tertiary alcohols [5]. Lipases are also able to accommodate cyclic esters, thioesters
and amines apart from triacylglycerols and aliphatic esters [18–20]. The chain-length
selectivity of lipases has been the subject of many studies [21–24]. Lipases mostly prefer a
range of medium (C6) to long (C16) chain-length with respect to the chain-length of fatty
acids [2]. However, there are some exceptions to this generalization such as Penicillum
roquefortti and Bacillus thermocatenulatus lipases and they hydrolyze only short chains
of C4.
1 .5 Structure
In 1990, the first lipase structure was crystallized by Brady [14]. In protein data bank,
there are more than one hundred 3D lipase structures available. According to these stud-
ies, some common features of all lipases are determined. One of the common features
is that all lipases are among the members of α-β (hydolase fold so that lipase structures
are composed of central sheets and surrounding helices [25–28]. Another one is that,
in a hairpin turn between an -helix and -helix or -sheet is placed the catalytic serine in
lipases. A highly conserved penta-peptide sequence of G-X-S-X-G is also found in this
region. This sequence forms a characteristic turn, which is referred as the nucleophilic
elbow [9, 26, 27]. Moreover, the active sites in lipases consist of three amino acids, ser-
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ine, histidine and aspartic/glutamic acid, which is common to another class of hydrolases,
serine-protease [14,29]. Compared to proteases, the structural arrangement of the residues
in active site is oriented to invert the stereochemistry of the catalytic triad in lipases, al-
though they have the same chemistry for their active sites [30]. There is an amphiphilic
lid found covering the active site of lipases [31, 32]. The composition and size of the lid
structure differs from lipase to lipase. The lid from the lipase of guinea pig has only five
amino acids where the lid from Bacillus thermocatenulatus lipase has two -helices which
corresponds to 20% of the whole lipase structure [28, 33].
In addition to the given features of lipase structures, the catalytic cleft in lipases are at-
tributed to specificity. The lipase clefts, fatty acid binding sites in particular, have been in-
vestigated and it came out that there are three different geometry that lipase structures may
exhibit; crevice-like, funnel-like and tunnel-like [34]. These differences in the binding
pockets is related to the diverse substrate specificities in lipases. Additionally, stereose-
lectivity depends on the steric interaction of the cleft with the substrate, so lipase structure
is also critical for understanding the stereoselectivity [35].
1 .6 Lipase in Industry
Enzymes are generally produced from bio-based elements by fermentation so that the
enzymes are entirely biodegradable and are able to be revitalized [38]. Lately, there has
been many improvements made in the production processes. These have led us that deliv-
ering enzyme concentrates at relatively low costs [39] is possible – encouraging enzyme
applications in the bulk industrial process.
Since the hydrolysis or production of many esters can be catalyzed by naturally oc-
curring fats and oils, they are the generally favored substrates of lipases [40–43]. With
their far-scaled spectrum of substrates, lipases are among the largest class of biocatalysts
considering the two coercing enzyme markets which are food processing and detergent
industry, are the mainly operations of lipases [42].
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Since lipases are able to catalyze reactions in aqueous and in organic media, they are
especially tempting for solving challenging synthesis of organic reactions [44]. Lipases
are particularly attractive for protein engineering applications because of their broad use
in industry consequent to their important products. The extracellular nature of micro-
bial lipases enables them to be produced easily at large quantities and to be isolated and
they are the favored source for many industrial applications. Being stable in organic sol-
vents, at high temperatures and ionic strengths, not requiring cofactors and having a wide
substrate selectivity and high enantioselectivity are among the main reasons for the high
Figure 1: (A) – Structure of mature Bacillus thermocatenulatus lipase 2, on which
amino and carboxyl termini, Zn2+, Ca2+ and cysteine 64 is labeled. [36] (B) – Structure
of Aspergillus niger lipase by homology modeling [37].
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industrial potential of microbial lipases [45]. Large number of articles and reviews stud-
ied in the molecular biology, biochemical and structural properties of lipases and their
biotechnological applications reflect the tempt in microbial lipases.
Removal of the pitch in pulp industry is also among the known applications of lipases.
The hydrophobic component of wood is called pitch and it must be removed before
processing. At low costs, the enzymatic removal of pitch is achieved via C. rugosa li-
pase [46]. Lipases are also used in the textile industry in order to bypass a process called
stoning, especially for denim production [47]. Abbreviated exposure to toxic chemicals
used in chemical process, which requires asbestos, is among the numerous advantages of
this enzymatic bypass mentioned above. Pharmaceutical industry also uses lipases be-
cause of their ability to synthesize enantio-pure drugs [48–50]. Ibuprofen for pain, Taxol
for cancer and Diltiazem for high blood pressure medications are examples to enantio-
pure drugs. The costs and drug toxiticy in pharmaceutical industry are reduced by the use
of lipases in enantioselective production of drugs.
1 .7 Protein engineering and Directed Evolution
Directed evolution is an in vitro process, where genetic mutations are generated and
inserted into a microorganism’s genome to analyze specific functional patterns and prop-
erties on molecular level. Directed evolution performs under the same fundamental prin-
ciples as natural evolution: the offsprings vary from the predecessor and selection crit-
era is the survival of the fittest. In nature, random mutation and recombination lead to
genetic diversification. Directed evolution requires a mechanism, for introducing those
genetic variations such as error prone PCR, nucleoside analogs [51], degenerate olignu-
cleotides [52], propagation in strains that lack DNA repair capabilities, growth in the
presence of chemical mutagens and DNA shuffling for recombination [53].
Mimicking the evolution in vitro would provide a better understanding of natural evo-
lution as well as allow the development of new enzyme activities. Since there is a con-
siderable interest in new biocatalysts, directed evolution became more widely used in
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industrial and academic laboratories in order to generate and modify enzymes [54].
Directed evolution in laboratory, necessitates a precise selection of a suitable starting
genes. A suitable candidate for molecular evolution is the class of α/β - barrel class of
proteins due to their wide spectrum of catalytic functions [54]. Evolution did its job by
evolving α/β - barrel to have a substrate binding sites within the barrel and the catalytic
residues within the connecting loop regions. These distinct regions, which are responsible
for specificity and catalysis, are suitable tools for their semi-autonomous evolution. And
this will lead to generate diversity in a combinatorial manner.
Protein engineering has been used as a key concept for producing biotechnologically
functional and novel biocatalysts. It has been applied on numerous fields such as oil
recovery enhancement, in which cellulosic ethanol has been produced [55], as well as
detergents, in which proteases are used [56], and polyester production via enzyme mod-
eling and engineering [57].
Since rational design introduces mutation(s) specifically for the desired properties of
certain protein sites and acquires numerous structural and functional parameters, as well
as characteristic information about the enzymes, itself and molecular evolution are the
fundamental approaches held for protein engineering. Despite the fact that molecular
evolution does not necessarily need any structural or functional information of the en-
zymes, randomly generated mutants need additional screening for establishing desired
properties.
To choose a best approach, limitations of both approaches should be considered thor-
oughly, such as methods for mutagenesis, information intensity that includes further de-
tails of structural and functional information, and selection and screening methods for
directed evolution techniques. Thereby, various strategies may result in a different out-
come, all having their certain advantages or disadvantages. The trade-off between rational
design efforts and screening can be given as an example. If X-ray crystal structures are
used for the rational design of a well-characterized and understood enzyme, it may limit
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screening to a few number of amino acid substitutions. On the contrary, if a powerful
screening method is applied, it may disregard the rational design altogether [58]. As a
result, choosing the optimal method depends on detailed information about the locations
for amino acid substitution, as well as the screening methods, group wise.
Another common target for protein engineering is to increase thermostability of a pro-
tein. A rigid and stable enzyme can be engineered, specifically functional at high temper-
atures, using the X-ray structure as one approach, following a design of stability interac-
tions such as disulfide bonds and/or salt bridges, as well as inserting Proline or removing
Glycine for stabilizing loops and focusing specifically on mutagenesis at flexible regions
of the desired enzyme [58].
Another improvement can be made on the catalytic activity and the enantioselectivity
of the enzyme, by substituting certain amino acid residues on the catalytic site of a target
protein that are closely located [57]. Certain strategies for introducing substitution in-
cludes shuffling, simultaneous mutagenesis (for multiple amino acid substitution), Error-
prone PCR, saturation mutagenesis (single amino acid substitution), and gene synthesis
for specific modifications [59]. While establishing multiple amino acid substitutions pro-
vides numerous possibilities and design parameters for a target protein, it may lead to a
loss in cooperative interactions and create a large library that has many idle variants. To
overcome this problem with cooperative interactions of multiple amino acid substitutions,
F.H. Arnold has suggested a stepwise accretion of single amino acid substitutions that has
each variant superior than the previous one [60].
To be able to locate paths for a specific derivative of a protein with desired properties,
all available paths should be tested beforehand. As an example, for an amino acid sub-
stitution that has five positions, there are 120 possible paths that leads to a final decisive
variant. In a study, the resistance of β -lactamase was enhanced with 18 paths at each stage
[61]. Thermostability of the enzyme phytase has been enhanced. After following 9 rounds
of optimization, Tyr277Asp mutation has been resulted as the only single base exchange,
10
while the other was double-base (three mutations) and three-base exchanges [62]. A prior
mutation earlier than the final variant being developed may lead to a dead end, as well as
random mutations at several sites. Nevertheless, this may cause further screening efforts,
therefore a well-designed selection method can be applied beforehand, as well as elimi-
nating unfolded or unstable proteins by reductionist assumptions [63,64] to diminish the
number of variants that needs to be screened [65].
It is probable to detect which mutations are more functionally beneficial for a particular
given characteristic by manipulating the data manually, if it’s a small dataset. However, as
more mutations are evaluated and screened for functional variance through each library,
the analysis of the data by hand becomes too complicated as it increases in size. Statistical
analysis introduced by ProSar uniquely analyzes the biological evolutionary relationship
between protein structure and activity and it compares the data for each variant that has
same or similar substitutionary information which in turn provides a clear understanding
about whether the particular substitution is functionally significant or non-functional at
all [66, 67]. In his study, G.W. Fox has used this statistical approach to successfully
observe the evolutionary path of a halohydrin dehalogenase [68].
As easily may be anticipated, there are numerous screening strategies, most of them
being either time or labor intensive. Most of the time, a final target variant can be missed
out due to a lack of a suitable and efficient screening-selection strategy. However, some
limited calorimetric screening methods can be developed for a limited number of enzymes
to overcome this complication. To be concise, the best protein engineering approach may
be defined as the one that brings the optimal solution with the least amount of effort and
with a time efficiency. Because of this reason, certain individual approaches should be
combined in order to produce the optimum outcome. For instance, due to the lack of a
suitable screening methodology for industrial enzymes used in directed evolution appli-
cations, and the difficulty of hitting the optimal substitution for an enzyme with desired
functionality in rational design, using these approaches individually is not a unique pro-
tein engineering approach. Instead, a combination of both strategies is crucial to provide a
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novel and efficient path for enhancing the functional and structural properties of enzymes
and thereby leading to rapid improvements in protein engineering.
1 .7.1 DNA shuffling
Stemmer had introduced DNA shuffling as a technique for in vitro recombination of
homologous genes, for accelerating evolution rate of certain genes to perform directed
evolution. The technology is highly used in applications such as gene therapy, vaccines,
small molecule pharmaceuticals, and so on [7]. DNA shuffling techniques mimic diver-
sity due to the merits of meiotic recombination. It is noted that libraries as large as 1015
molecules can be constructed by directed evolution. This may be considered as a draw-
back in terms of challenges at screening procedures; however, it is more of an advantage
in terms of obtaining more recombinations that facilitates the production of a targeted
enzyme, which is aimed to be utilized in industrial applications. As well as recombining
DNA fragments, point mutations are also introduced to the sequence with a low rate, nat-
urally propose a high-throughput methodology – both accelerating rate of evolution and
obtaining the desired features for functionality, which leads to a novel advancement in
industrial applications [7].
The classical DNA shuffling method is basically performed by digesting specific genes
by DNAse I enzyme and attaining pieces of different types of genes shuffled together
and reassembled under optimized PCR protocol, followed by integration into vectors and
transformation into the target organisms [69,70].One of the advantages of DNA shuffling
is that, after the gene to be improved is introduced with a point mutation, there is a vari-
ety of beneficial mutations which are low on frequency relative to deleterious mutations,
which then can be added to the cycle one at a time, building more beneficial mutations
that eventually give out the best mutant from that given cycle [7]. Suen et al. (2004), have
used DNA shuffling method on Candida antartica lipase (CALB) to obtain chimeric li-
pase B. The obtained lipase have shown 20 fold increase in activity and 11 fold increase in
the 45oC half life towards the diethyl 3-(3’,4’-dichlorophenyl) glutarate (DDG) substrate,
compared to it’s wild type [71]. Yu et al. (2012) have also used DNA shuffling method
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to increase heat resistance of Rhizopus chinernsis lipases. The half life of the obtained
mutant at 60oC and 65oC have increased by 46 and 23 fold, respectively [72].
Directed evolution has played a significant role in improving the performance of an
enzyme (or create one) through introducing new features that natural selection normally
would not necessarily provide [73], as well as enhancing the selection criteria to yield
targeted properties for that specific enzyme or microorganism, through custom schemes.
A lead enzyme is picked and mutagenized, followed by selection or screening which
results in improved variants that contains the target evolved enzyme. Protein molecules
can be altered due to their structural and functional properties, which in turn can increase
their thermal stability or introduce a new functionality (enzyme engineering), as well as
changing the topology or structure, and altering the existing properties for improvement.
While creating new enzymes improved for applications in industry and biotechnology,
directed evolution methods can also be applied to improve limitations of certain functions
of proteins, via accumulating beneficial mutations that lead to an augmentation of the
enzyme’s activity. In a study, it has been noted that the improved enzyme previously
containing 10 amino acid substitution is enhanced by 157-fold [73].
13
2 Materials and Methods
2 .1 Molecular Cloning
Bacillus thermacatenulatus lipase gene(BTL2), which is 1,167 bp DNA fragment, and
Aspergillus niger lipase gene(ANL), which is 891 bp, are amplified from the mature li-
pase clones (pMCSG7 - BTL2 and ANL). Primer sets are containing ligation indepen-
dent cloning (LIC) sites; for forward (F BTL2 LIC : 5’- TACTTCCAATCCAATGC-
CGCGGCATCCCCACGC - 3’ and F ANL LIC: 5’ - TACTTCCAATCCAATGAAAT-
GTTCTCTGGACGGTTTG - 3’) and for reverse (R BTL2 LIC: 5’ - TTATCCACTTC-
CAATGTTAAGGCCGCAAACTCGCC - 3’ and R ANL LIC: 5’ - TTATCCACTTC-
CAATGAATAGCAGGCACTCGGAAA - 3’). PCR conditions are the following: 5 min
at 94 oC, 35 cycles of 30 sec at 94 oC, 30 sec at 53 oC, 1 min at 72 oC, 10 min at 72 oC.
After DNA shuffling procedures, 4µg of expression vector, pMCSG7, is linearized using
SspI restriction enzyme (see Appendix A.1 for vector map). Linear vector and insert are
elecroporated at 135 V in 1.5% agarose gels using tris borate EDTA (TBE) buffer sys-
tem for 20 minutes. Both fragments are extracted from agarose gel and treated with T4
DNA Polymerase. The exonuclease activity is restricted using excess amount of dGTP
for vector and dCTP for the inserts according to the given LIC sequences. The reaction
is carried on for 50 minutes at 20oC followed by heat-activation at 70oC for 20 minutes.
Phenol/chloroform extraction and ethanol precipitation procedures are applied to the T4
DNA polymerase treated DNA samples. Vector (in 5 µl) and shuffled lipase genes(in 3µl)
solubilized in distilled water and annealed at 23oC for 16 hours. E.coli Shuffle chemically
competent cells are prepared according to Maniatis et al [74]. All the annealing reaction
after 16 hours are transformed into E.coli Shuffle cells by using a chemical transforma-
tion method [75]. For colony PCR , ANL LIC and BTL2 LIC primer pairs are used in
the given PCR cycle profile for the selected colonies. PCR products, which are ampli-
fied by Colony PCR reaction, are run in 1.5% agarose gel using GeneRuler 1kb DNA
Ladder SM0311(Fermentas). To the colony PCR positive clones, plasmid purifications
are applied. The plasmid purifications are done using Qiagen Plasmid Purification kit .
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Plasmids are sequenced using the primer set combinations which are used at the DNA
shuffling process by Molecular Cloning Laboratories (MCLAB).
2 .2 DNA Shuffling
PCR products of ANL and BTL2 genes, which are amplified with the PCR cycle men-
tioned above, are purified using Qiagen PCR Purification Kit. 1.2µg DNA from ANL
and BTL2 is mixed in a tube and digested with 0.05 U DNase(Roche,10 U/µl) in 10X
digestion buffer with MnCl2 for 75, 90 and 120 min at room temperature. The reaction is
inactivated with 2.5 mM EDTA and incubation at 85oC for 5 minutes. The mixtures are
run in 2% agarose gel. Fragments that are lower than 50 base pairs in size and between
50 and 100 base pairs are extracted from the gel by using QIAEX II gel extraction kit.
Extracted fragments are reassembled by the previous PCR cycles but without the primers.
Amplification of the reassembled fragments are made through the same PCR reaction us-
ing the assembled fragments as the template but the primer combinations of ANL and
BTL2 were added. Amplified reassembled fragments are cloned to pMCSG7 expression
vector by ligation independent cloning.
2 .3 Lipase Expression
Shuffled genes are transformed to Shuffle E.coli by chemical transformation. Trans-
formed cells are plated on LB-Agar plates with Ampicillin. Colonies, which survived,
inoculated on LB- Rhodamine, which has IPTG (isopropyl-β -D-thiogalactopyranoside),
plates to check the qualitatively check the lipase activity. All possible mutants are also
expressed in suspension culture using 1mM IPTG in LB broth. The expressions are lasted
out for eight hours and sampled once at fourth hour. The cells are harvested by cen-
trifugation (for 5 min at top speed) and lysed by using B-PER(Thermoscientific). After
centrifugation at maximum speed for 10 min, lipase activity of soluble fractions is deter-
mined using fluorescent substrates, 4MU-C8 in 0.1M Tris at pH 7.25. SDS-PAGE gel is
run to analyze the soluble fractions and visualized by coommassie staining.
15
2 .4 Lipase Assays
Lipase activity is determined in two different ways:
2 .4.1 Rhodamine plate assays
Selected colonies are inoculated on to the Rhodamine-LB agar plates which are con-
taining IPTG (for expression), oil (as substrate), Rhodamine(dye that interacts with free
fatty acids) and LB agar. When the expression starts at the inoculated colonies, expressed
recombinant lipases start to hydrolyze oil. Fatty acids which yielded from the hydrol-
ysis reaction interacts with the Rhodamine dye and gives light under UV. Preliminary
detection of active recombinant enzymes is achieved by this screening technique.
2 .4.2 Fluorescence assay
For more quantitative measurement, lipase activity is measured with fluorescent assay
methods. For fluorescent assays, lipase activity measured in a 96-well black micro titer
plate using 4MU - caprylate as the substrate. Expression medium, which do not contain
any cell, assayed in reaction medium of 100 mM Tris-Cl at pH 7.25. 4MU fluorescence
is measured by using Gemini XS (Molecular Devices) using wavelength of 355 nm for
excitation and an emission wavelength of 460 nm. For one hour, in every minutes, mea-
surements are taken. All assays are made in duplicates and initial velocities are calculated
using SoftMax Pro Software (Molecular Devices). Relative Fluorescent Unit obtained
from fluorometer is converted to 4MU units with respect to the linear relationship ob-
tained from 4MU standard curve.
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2 .5 Lipase Characterization
2 .5.1 Thermostability
Soluble fractions of the clones that do have expressions, are used in fluorescent assays
to profile thermostability by quantifying the residual activity of lipases after 30 minutes
of incubation at temperatures 30oC, 40oC, 50oC, 60oC, 70oC, and 80oC is set to 100%
activity for calculating the percent activity.
2 .5.2 Substrate specificity
Chain length specificity of the mutated lipases are screened by fluorescent enzyme
assays using reaction medium of 100 mM Tris-Cl at pH 7.25 as the reaction buffer. From
the chain lengths of 2C to 16C the following lipids are used; Acetate(2C), propionate(3C),
butyrate(4), caproate(6C), enatiothe(7C), caprylate(8), and palmitate(16C).
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3 Results
In this study, DNA shuffling method has been successfully performed on ANL and
BTL2 genes in order to generate randomly mutated novel lipases. The reason ANL and
BTL was chosen as candidates due to their evolutionary distance, in which they share 42%
identity. Furthermore, the fact that Bacillus thermocatenulatus lipase is thermophilic and
Aspergillus niger lipase is mesophilic, DNA shuffling on these candidate lipases could
lead to obtain the expected features such as wide range of temperature, pH, which re-
markably appeals to industrial and biotechnological applications.
Due to the fact that DNA shuffling introduces random mutagenesis, numerous mutants
can be produced in a single run, which in turn enables an increase in the shuffled gene
library size. In our experimentation, multiple optimization experiments have been held
for DNase digestion to obtain the desired fragment size (50bp), using time, temperature
and DNA concentration as parameters. Using regular cloning methodology, randomly
mutated library has been transformed into Shuffle type E.coli cells. For screening, only
qualitative plate assay has been performed, and for sequencing, sequencing data have
been obtained and analyzed from libraries to detect random mutations.
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Figure 2: PCR amplifications of (a) ANL (891bp), and, (b) BTL2 (1167bp).
Arrowheads show the plasmids. M: MassRuler DNA Ladder Mix (Fermentas).
ANL and BTL2 genes were amplified from the mature lipase clones, pMCSG7-ANL
and BTL2 , by using their specific primers. PCR conditions are the following: 5 min at 94
C, 35 cycles of 30 sec at 94 oC, 30 sec at 53 oC, 1 min at 72 oC, 10 min at 72 oC. In Figure
2, the bands that appeared above the PCR product indicates presence of the plasmid which
is used as the template. This plasmid would spoil the DNase digestion.
In order to eliminate plasmid interference, Dpn2 digestion applied to the PCR products
at 37C for overnight. In Figure 3 , digested plasmid fragments are shown with arrow
heads. PCR products were extracted from the agarose gel.
Figure 3: Dpn2 digestion of the plasmids carrying (a) ANL, and (b) BTL2. Arrowheads
show the digested plasmid fragments. U: Uncut PCR products for (a) ANL, and (b)
BTL2. M: MassRuler DNA Ladder Mix (Fermentas).
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Figure 4: Purified PCR products for ANL and BTL2, excised and extracted from the
agarose gel shown in Figure 2. M: MassRuler DNA Ladder Mix (Fermentas).
Extracted PCR products are run on 1.2% agarose gel in order to confirm that there is no
plasmid left in the mixture. So Figure 4 indicates that the PCR products are plasmid-free
and ready to DNase digestion.
DNase digestion is applied to PCR products. 2 µg DNA from ANL and BTL were
digested separately with 0.05 unit of DNase I (Roche). As the reaction buffer, 10X diges-
tion buffer which is 500mM Tris-HCl pH 7.4 and 100mM MnCl2 is used. The digestion
was done at room temperature until it is terminated after 20 minutes by heating at 85oC
with the presence of 2.5mM EDTA. Mixture is run on 2% agarose gel. Smear on Figure
5 shows the digested fragments of the particular genes. Fragments from 150 to 300bp are
excised and extracted from the gel.
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Figure 5: DnaseI digestion of ANL and BTL2 PCR Products. DNA smears indicative of
digestion products of varying lengths, as low as 200bp, are evident. M: GeneRuler Ultra
Low Range DNA Ladder (Fermentas).
Figure 6: Digest products from DnaseI-treated ANL and BTL2 mixtures at different
time points as given at the bottom. M: GeneRuler Ultra Low Range DNA Ladder
(Fermentas).
20 minutes of digestion was not sufficient for obtaining the desired fragment size which
is smaller than 100 base pair. So DNase digestion is applied to PCR products. This time
1,2 µg of each gene from were mixed and digested in a tube with 0.05 unit of DNase
I (Roche). As the reaction buffer, 10X digestion buffer which is 500mM Tris-HCl pH
7.4 and 100mM MnCl2 is used. The digestion was done at room temperature. 15, 20,
23, 27, 32, 38, 45, 53, 60 minutes of digestion was done in order to find out the most
efficient digestion time point. Inactivation is done by heating the samples at 85C with the
presence of 2.5mM EDTA. Mixture is run on 2% agarose gel. Smears on Figure 7 show
the digested fragments of the particular genes.
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Same protocol used at Figure 5 was applied for 75 minutes, 90 minutes and 120 minutes
in order to obtain smaller fragments(smaller than 50bp). Inactivation is done by heating
the samples at 85C with the presence of 2.5 mM EDTA. Mixture is run on 2% agarose
gel. Smears on Figure 8 show the digested fragments which are in the range of desired
fragment size. Fragments below 50bp and between 50 -100bp are excised and extracted
from the gel followed by the reassembly PCR.
Figure 7: Digest products from DnaseI-treated ANL and BTL2 mixtures at different
time points as given at the bottom. M: GeneRuler Ultra Low Range DNA Ladder
(Fermentas).
22
Figure 8: Amplification PCR with the primer combinations. M: MassRuler DNA
Ladder Mix (Fermentas).
In figure 7, Group A indicates the reassembled 50bp and below fragments, while Group
B indicates the reassembled fragments in the range of 50-100 bp. Lastly, Group C in-
dicates the reassembled ANL fragments which are 150-300 bp in length. The primer
combinations are; (1) F ANL - R ANL, (2) F BTL, R BTL, (3) F ANL, R BTL, and
(4) F BTL, R ANL. A1, B1 and C1 labeled samples, which are produced by using ANL
primer sets, are detected on 1,2% agarose gel. The amplified fragments were excised and
extracted from the gel.
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Extracted shuffled genes are cloned to expression vector pMCSG7 by ligation indepen-
dent cloning and transformed into Shuffle E.coli competent cells by chemical transforma-
tion. As a result of the transformation, 75 colonies (37 colonies from A1, 18 colonies from
B1, 20 colonies from C1) were obtained on LB-agar plates. Colony PCR was performed
to check the insertion of the shuffled genes into the transformed vectors. It is confirmed
that all colonies had the insert, shown in Figure 9.
Figure 9: Colony PCR of obtained colonies.
Obtained A1 colonies are inoculated to LB - rhodamine activity plates to decide the
activity of the possible mutants qualitatively. All the colonies except colony 33 had the
lipase activity (Figure 10).
Figure 10: LB-Rhodamine activity plates of A colonies.
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Obtained B1 colonies are inoculated to LB - rhodamine activity plates to decide the
activity of the possible mutants qualitatively. The LB- rhodamine plate of B1 combination
showed that most of the colonies have the lipase activity (Figure 11).
Figure 11: LB-Rhodamine activity plates of B colonies.
Obtained C1 colonies are inoculated to LB - rhodamine activity plates to decide the
activity of the possible mutants qualitatively. Inoculated 14 C1 colonies out 20 have the
lipase activity on LB-rhodamine plates (Figure 12).
Figure 12: LB-Rhodamine activity plates of C colonies.
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To screen the mutations which occurred by DNA shuffling, plasmid isolation is applied
to all 75 colonies and the purified plasmids are sent to sequencing with R ANL primer.
Alignment of the samples with ANL and BTL2 native genes shows that samples have
similarity more than 90% with ANL gene. Although, samples mostly similar to ANL,
eight of the samples have point mutations which may lead to the activity change. In fact,
colony A33 has 10 point mutations which lead to the loss of activity. Point mutations at
these eight samples are listed at Table 1. There are point mutations in these samples that
would normally lead to activity loss but didn’t caused any activity loss such as Asp to Gly
mutation at colony B15 or Gly to Ser mutation at colony C15 or Thr to Ala at colony C15.
Clone Location of the Mutation Amino acid Substitution Activity
A33 60th amino acid GUG (Val)→ GUA (Val).
A33 64th amino acid GCC (Ala)→ ACC (Thr)
A33 68th amino acid CCU (Pro)→ GCU (Ala)
A33 95th amino acid GCC (Ala)→ GUC (Val)
A33 106th amino acid GCC (Ala)→ UCC (Ser) (-)
A33 124th amino acid CUC (Leu)→ CUU (Leu)
A33 160th amino acid GCC (Ala)→ GAC (Asp)
A33 184th amino acid AGC (Ser)→ AAC (Asn)
A33 214th amino acid ACG (Thr)→ GAG (Glu)
A33 250th amino acid AGC (Ser)→ AAC (Asn)
B2 3rd amino acid UCU (Ser)→ UAU (Tyr)
B2 44th amino acid UCU (Ser)→ UCC (Ser) (+)
B2 46th amino acid GCA (Ala)→ GCG (Ala)
B8 188th amino acid AAU (Asn)→ AAC (Asn) (+)
B15 65th amino acid GAC(Asp)→ GGC(Gly)
B15 61st amino acid AAU(Asn)→ AGU(Ser) (+)
C6 61th amino acid ACA(Thr)→ GCA(Ala)
C6 275th amino acid GGU(Gly)→ GAU(Asp) (+)
C12 137th amino acid CAC(His)→ CGC(Arg) (+)
C14 86th amino acid AAC(Asn)→ GAC(Asp) (+)
C15 31th amino acid ACU(Thr)→ GCU(Ala)
C15 151th amino acid CUG(Leu)→ CCG (Pro)
C15 176th amino acid GGC(Gly)→ AGC (Ser) (+)
C15 223th amino acid GUU(Val)→ GCU(Ala)
Table 1 : Types of point mutations and their locations on the sequence.
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The locations of the mutations of particular colonies given in table 1 were investigated.
Since the colonies have more than 90% identity with ANL, homology model of ANL
is used to locate the point mutations which are detected. Homology model of ANL is
made by using Thermomyces lanuginosa lipase structure as the template. They have
51% sequence similarity with the query coverage of 99%.
Figure 13: Homology modeling of Aspergillus niger lipase, using 1dt3 (Thermomyces
lanuginosa lipase) as the template.
Figure 14: The Lid domain has been shown from top and side view, respectively. The
predicted model corresponds to the inactive lipase form where the lid is in its closed
conformation.
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The best candidate for the Lid domain is shown in Figure 14 in yellow. The reason
for chosen as best candidate is because the catalytic Serine has also been covered. Also,
the amino acid content of the lid explains the interfacial properties of the lipase. In the
closed conformation, the polar residues like, N, D and T are exposed to solvent. In the
open conformation, the non-polar residues like W, I and V should be exposed to the lipid-
interface.
Multiple sequence alignment is applied to all mutants (see Appendix A.2), which are
obtained from sequencing, with native ANL. Afterwards, locations of the point muta-
tions, which are detected from sequencing data, pointed with arrows (Red = ”deadly”
mutations, Blue = ”compensating” mutations, Grey = ”silent” mutations) and in addition,
only ”deadly” mutations which indicates non polar amino acid - polar amino acid change,
are shown on the homology model of ANL by using VMD (Visual Molecular Dynamics).
Figure 15: Multiple sequence alignment of Colony A33.
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Colony 33 had 5 “deadly”, 5 “compensating” and 1 “silent” mutations. As it can be
seen from Figure 15, 2 out of 5 deadly mutations are located at core of the protein. In
fact, T184E mutation located on the nucleophilic elbow (in Magenta color) which carries
the catalytic serine residue. And the A146D mutation is located at the adjacent β -sheet to
the nucleophilic elbow. Locations of these 2 mutations make them important due to their
closeness to the catalytic site.
Figure 16: Locations of the mutations for Colony A33. The nucleophilic elbow that
carries the catalytic serine is shown in magenta.
For the mutations at the colonies B2, B8, B15, C12 and C14, they are either “deadly”
but surface exposed or silent mutations which are unlikely to cause a change in activity
of the enzyme. At the colony B2, three codon changes have occurred, two of them being
silent mutations (Serine to Tyrosine on the 3rd amino acid, Serine to Serine on the 44th
amino acid, and Alanine to Alanine on the 46th amino acid, respectively). At the colony
B8, Asparagine to Asparagine change has occurred on the 188th amino acid. At the colony
B15, two codon changes have occurred, an Aspartic acid to Glycine on the 65th amino
acid, and an Asparagine to Serine on the 61st amino acid. At the colony C12, a Histidine
to Arginine substitution has occurred on the 137th amino acid, and at the colony C14, an
Asparagine to Aspartic acid substitution on the 86th amino acid.
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Figure 17: Multiple sequence alignment of Colony 39 (B2).
Figure 18: Multiple sequence alignment of Colony 45 (B8).
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Figure 19: Multiple sequence alignment of Colony 52 (B15).
Figure 20: Multiple sequence alignment of Colony 61 (C6).
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Figure 21: Locations of the mutations for Colony 61 (C6)
Colony C6 has 2 “deadly” mutations which are Threonine to Alanine substitution at
61st amino acid which is surface exposed and far away from the catalytic site. The other
one is the Glycine to Asparagine substitution at the 275th amino acid which is located
more closely to the catalytic site (Figure 20). Since this is also a non polar to polar
substitution, the mutation has a role in changing the activity.
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Figure 22: Multiple sequence alignment of Colony 67 (C12).
Figure 23: Multiple sequence alignment of Colony 69 (C14).
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Figure 24: Locations of the mutations for Colony 69 (C14).
Figure 25: Multiple sequence alignment of Colony 70 (C15).
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Figure 26: Locations of the mutations for Colony 70 (C15).
Colony C15 has 3 “deadly” mutations which are Threonine to Alanine substitution at
31st amino acid Leucine to Proline substitution at 151st amino acid, Glycine to Serine
substitution at 176th amino acid (Figure 25). 2 out of these 3 “deadly” mutations are
likely to effect the activity of the enzyme. G176S mutation is very much at the core of
the protein and is significantly close to the catalytic site. This kind of mutation (non-polar
to polar) would be significant since there will be a presentation of a polar amino acid at
the core of the protein. Another significant “deadly” mutation would be L151P because a
presentation a Proline in to a existing α-helix would cause rupture the α helical structure
which is also likely to change the activity of an enzyme.
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Figure 27: The relative activity plot of the colonies, using fluorescence enzyme assays.
As a substrate, 4MU-caprylate has been used to detect the activity of lipase from the
soluble fraction.
For quantitatively determining the lipase activity, fluorescent lipase assay methodology
is applied. 5 micro liters of the soluble fraction from the cultured cells are assayed by
using 4MU - caprylate as the substrate. Soluble fraction of the cultured cells, which do
not contain any cell, assayed in reaction medium of 100 mM Tris-Cl at pH 7.25. 4MU
fluorescence is measured by using Gemini XS (Molecular Devices) using wavelength of
355 nm for excitation and an emission wavelength of 460 nm. As it is shown in Figure
26 the mutations caused a decrease on the lipase activity at clones A33 and C6, as well
as increase in activity of clone C15 by 25%. These activity changes may be due to the
“deadly” mutations that are presented near the catalytic site. To investigate whether the
mutations caused a change in substrate selectivity and due to that the activity loss against
caprylate has occurred or it is the general activity loss, a substrate selectivity assay is
made. From the chain lengths of 2C to 16C the following lipids are used; Acetate(2C),
propinate(3C), butyrate(4), caproate(6C), enatiothe(7C), caprylate(8), and palmitate(16C)
for the investigation of the substrate selectivity. As it is shown in Figures 27, 28, 29 and
30, there is no detectable change in the substrate selectivity trend with respect to the
control group which is the native ANL.
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Figure 28: Substrate selectivity assay of native ANL. From the chain lengths of 2C to
16C the following lipids are used; Acetate(2C), propinate(3C), butyrate(4),
caproate(6C), enatiothe(7C), caprylate(8), and palmitate (16C).
Figure 29: Substrate selectivity assay of clone A33. From the chain lengths of 2C to
16C the following lipids are used; Acetate(2C), propinate(3C), butyrate(4),
caproate(6C), enatiothe(7C), caprylate(8), and palmitate (16C).
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Figure 30: Substrate selectivity assay of clone 61 (C6). From the chain lengths of 2C to
16C the following lipids are used; Acetate(2C), propinate(3C), butyrate(4),
caproate(6C), enatiothe(7C), caprylate(8), and palmitate (16C).
Figure 31: Substrate selectivity assay of clone 70 (C15). From the chain lengths of 2C
to 16C the following lipids are used; Acetate(2C), propinate(3C), butyrate(4),
caproate(6C), enatiothe(7C), caprylate(8), and palmitate (16C).
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Figure 32: Thermostability assay of clone 33 (A33), 61 (C6), and 70 (C15).
Soluble fractions of the clones that do have expressions, are used in fluorescent assays
to profile thermostability by quantifying the residual activity of lipases after 30 minutes
of incubation at temperatures 30oC, 40oC, 50oC, 60oC, 70oC, and 80oC is set to 100%
activity for calculating the percent activity. As it is shown at the results, C6’s and C15’s
activity peak shifted to around 40oC whereas A33’s has peaked at the same with control
but has higher activity on the particular temperatures. This may due to the various mu-
tations located at the different places at the structure. Although, the activity of A33 is
decreased 20% , it’s thermostability is slightly better.
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4 Discussion and Conclusion
Here, it is reported that DNA shuffling is a suitable methodology for generating ran-
domly mutated lipase libraries for industrial usage. In this study, instead of family shuf-
fling, which is a common preferred method for random mutagenesis of an enzyme, non-
family shuffling has been tried. ANL, which is a fungal lipase, and BTL2, which is a
bacterial lipase, were shuffled in order to obtain a mutant library which would have the
desired features such as increased thermostability, and broader substrate specificity.
To the best of our knowledge, this study describes the first application of DNA-shuffling
of lipases from B. thermocatenulatus and Aspergillus niger. As it can be seen from mul-
tiple alignments, the clones which are obtained from this study are not chimeric proteins.
Multiple sequence alignments of the clones do not produce hits for BTL sequence and
moreover, they all have at least 99% sequence identity to ANL sequence. This may due to
the usage of genes from different families. Although ANL and BTL have 41% sequence
homology, they didn’t shuffle, as can be deduced from the results. It can be speculated
that the reason for not seeing any chimeric proteins would be the slight difference in
their codon usage. Due to this, the chimeric proteins couldn’t have survived during the
cloning selection. The reason of not seeing any BTL self-shuffled proteins would be the
evolutionary difference between fungi and bacteria, since their codon usage is related to
their evolutionary path as well. Evolution of synonymous codon usage is reported to be
decided by a balance between mutation, genetic drift and natural selection. However, nat-
ural selection on codon usage is considered to be a weak evolutionary force and selection
on codon usage is expected to be the strongest force [76]. Reported point mutations may
come from self shuffling of ANL fragments which could lead to point mutations as well
or it may come from the errors of the DNA polymerase. The second case is not likely
since Pfu DNA polymerase is used and Pfu has high fidelity. Therefore, it can be reported
that these mutations are coming from the self shuffling of the ANL fragments. There are
also studies which indicate that using single genes and random point mutations which
are generated by shuffling of the single gene is also a source of diversity [53, 77]. Self
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shuffling or family shuffling utilizes naturally occurring nucleotide substitutions as the
driving force for the evolution in vitro. It is also reported that multiple rounds of shuf-
fling would increase the recombination and the mutations yield [77]. Thereby, in further
studies, shuffling of the clones which are obtained from this study can be used to generate
different mutations and more evolved clones.
From a single round of DNA-shuffling with these two parent lipases, three mutants
(A33, C6, C15) with various point mutations have occurred, which could normally cause
an activity loss (non polar - polar /charged amino acid substitution). In this case, only
A33 and C6 clones show activity loss around 20% due to the point mutations. Activity
loss of these clones may occur due to the mutations that are located at a close proximity to
catalytic site. In A33 clone, T184E mutation which is located on the nucleophilic elbow
is likely to cause the activity loss and the C6 G92D mutation may be the responsible of
the activity loss due to the fact that they are close to the catalytic triad and also located at
the core of the protein.
Since the aim of this project was to generate the library that could be investigated on
further studies, the mutant proteins are not purified. However, substrate selectivity and
thermostability assays are effectuated, with the soluble fraction of the cells to shed light
on the features of the lipases as a preliminary examination. As it is mentioned at the results
section, there are no changes in the substrate selectivity trend with respect to the control’s
substrate selectivity trend. In this case, this is expected, since the point mutations are not
in close proximity with amphiphilic lid of the lipases. All three clones and the control
have the highest activity against caprylate (8C) and the lowest activity against palmitate
(16C).
Their thermostability features are more diverse than their substrate selectivity. As it is
shown in the results, C6’s and C15’s activity peak shifted to around 40oC whereas A33’s
has peaked at the same with control but has higher activity on the particular temperatures.
This may be due to the various mutations located at the different places at the structure.
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These mutations may have lead to decreased flexibility of A33 clone and therefore it
might cause an increase in thermostability. Although the activity of A33 has decreased by
20% , it’s thermostability is slightly better. Again this may due to synergistic effect of all
point mutations but the A146D and T184E mutations could have a crucial effect on both
flexibility and the activity of the protein. The reason for the thermostability shift of clone
may again be caused by the G92D mutation because this mutation would lead an increase
on flexibility of the protein therefore decrease in thermostability. In clone C15, there is
a G176S mutation at the core of the protein and a L151P mutation at a helical structure
which would break the helix and would turn it to loop or multiple helices. As it can be
seen from the bar graph of thermostability, thermostability trend of clone C15 is shifted
around 40oC and it is more likely that this shift is caused by the L151P mutation because
since proline mutation breaks the α helical structure, the flexibility of the protein would
increase and therefore again it would lead to a decrease in thermostability. Although the
thermostability trend is shifted in C6 and C15, their activity is not dead even in 80oC. It
may be caused by the other proteins in the soluble fraction of the cells. To find out the
real stability of these enzymes further studies like purification and same characterization
experiments should be performed.
These point mutations may affect substrate binding and/or regulate the reaction rate for
the hydrolysis of the covalent reaction intermediate. Therefore, it could affect the activity
change. Also, synergistic effects of mutations may occur and lead up to the getting the
desired functions for the industrial applications.
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A Appendix A
A.1 DNA ladders and Experimental Protocols
Figure A.1 : DNA molecular weight markers, Ultra low range and 1kb ladders,
respectively.
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A.1.1 Vector (pMCSG-7) Overnight Digest with Ssp1
pMCSG-7 (his-tagged bacterial expression vector) is a vector that is transformed into
E.coli and expressed as 6 x His-tagged-protein complex. This vector was digested by
restriction enzyme digestion. The restriction enzyme was chosen as Ssp1.
Figure A.2 : pMCSG -7 (his-tagged bacterial expression vector)
The restriction enzyme digestion of pMCSG-7 was performed according to the table
below:
pMCSG-7 50µl
Ssp1 2µl
Green Buffer 6µl
ddH20 2µl
Table A.1 : Procedure for the restriction enzyme digestion of pMCSG-7
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A.1.2 Gel Electrophoresis Procedure
For the gel electrophoresis the general protocol was applied as indicated below.
• Take 50X TAE buffer, dilute it to 1X by adding 10 ml to 490 ml water.
• Weight 1 gr agarose; dissolve it in 100 ml 1X TAE buffer.
• Heat the solution until full homogeneity is obtained.
• Cool the solution; add 2 l EtBr; mix the solution to solve EtBr.
• Pour solution to the rack; place comb; wait till polymerization.
• Place the rack onto the container; fill the container with 1X TAE buffer.
• Place the samples to the wells.
• Run the machine for 30 min; later on, check the gel under UV light.
• If necessary run for additional minutes.
Gel Extraction
After the agarose gel electrophoresis of PCR products and pMCSG-7 overnight digest
with Ssp1, the samples are extracted from the gel for obtaining pure reaction products.
QIAGEN- QIAquick Gel Extraction Kit Protocol was performed as listed.
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel.
2. Weigh the gel slice in a colorless tube. Add 3 volumes Buffer QG to 1 volume gel
(100 mg 100 µl). For > 2% agarose gels, add 6 volumes Buffer QG.
3. Incubate at 50oC for 10 min (or until the gel slice has completely dissolved). Vortex
the tube every 2–3 min to help dissolve gel.
4. After the gel slice has dissolved completely, check that the color of the mixture is
yellow (similar to Buffer QG without dissolved agarose). If the color of the mixture
is orange or violet, add 10 µl 3 M sodium acetate, pH 5.0, and mix. The color of
the mixture will turn yellow.
5. Add 1 gel volume of isopropanol to the sample and mix.
6. Place a QIAquick spin column in a provided 2 ml collection tube or into a vacuum
manifold.
7. To bind DNA, apply the sample to the QIAquick column and centrifuge for 1 min or
apply vacuum to the manifold until all the samples have passed through the column.
Discard flow- through and place the QIAquick column back into the same tube. For
sample volumes of > 800 µl, load and spin/apply vacuum again.
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8. If the DNA will subsequently be used for sequencing, in vitro transcription, or micro
injection, add 0.5 ml Buffer QG to the QIAquick column and centrifuge for 1 min
or apply vacuum. Discard flow-through and place the QIAquick column back into
the same tube.
9. To wash, add 0.75 ml Buffer PE to QIAquick column and centrifuge for 1 min or
apply vacuum. Discard flow-through and place the QIAquick column back into the
same tube.
Note: If the DNA will be used for salt-sensitive applications (e.g., sequencing,
blunt-ended ligation), let the column stand 2–5 min after addition of Buffer PE.
10. Centrifuge the QIAquick column once more in the provided 2 ml collection tube
for 1 min at 17,900 x g (13,000 rpm) to remove residual wash buffer.
11. Place QIAquick column into a clean 1.5 ml micro centrifuge tube.
12. To elute DNA, add 50 µl Buffer EB (10 mM Tris · Cl, pH 8.5) or water to the center
of the QIAquick membrane and centrifuge the column for 1 min. For increased
DNA concentration, add 30 µl Buffer EB to the center of the QIAquick Membrane,
let the column stand for 1 min, and then centrifuge for 1 min. After the addition
of Buffer EB to the QIAquick membrane, increasing the incubation time to up to 4
min can increase the yield of purified DNA.
13. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading Dye to 5
volumes of purified DNA. Mix the solution by pipetting up and down before loading
the gel.
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A.1.3 T4 DNA Polymerase Reaction
For ligation independent cloning vector and insert were modified according to T4 DNA
Polymerase reaction which creates guanine overhangs for vector and cytosine overhangs
for insert.
Table A.2 : T4 DNA Polymerase Reaction Program
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A.1.4 Phenol/Chloroform Extraction and Ethanol Precipitation
Phenol/Chloroform extraction and ethanol precipitation is carried out for both vector
and insert in separate tubes based on the following procedure.
• Product of T4 DNA polymerase reaction for vector (80 µl) was completed up to
100 µl with ddH2O
• Product of T4 DNA polymerase reaction for insert (70 µl) was completed up to 100
µl with ddH2O.
• Addition of 1:1 ratio phenol/chloroform (100 µl) into both tubes.
• Vortex
• 5’ of top speed centrifuge (13.2 rpm)
• Take supernatant
• Addition of 4 µl NaOAc, 10 µl LPA and 250 µl EtOH (%100)
• Keep the tubes at-80oC for 20’
• 15’ Top speed centrifuge (13,2 rpm)
• Discard the supernatant
• Addition of 250 µl EtOH (%70) onto the pellet
• 10’ Top speed centrifuge
• Discard the supernatant
• Re-suspend the pellet with 10 µl of ddH2
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A.1.5 Annealing Reaction
Purified vector and insert were combined together by annealing reaction at 22oC for
45’– 60’.
Table A.3 : Annealing reaction
A.1.6 Transformation to Shuffle Competent Cells
For the transformation of plasmid into the competent cell, the following procedure was
carried out.
• Mix 2 µL product of annealing reaction with 200 µL of each competent cells
• Keep on ice for 20’
• Heat shock for 1’ at strictly at 42oC
• Keep on ice for 10’
• Addition of 800 µL SOC
• Incubation at 37oC for 60’
• Centrifuge at 7000 rpm for 2’
• Discard the supernatant until 100 µL of supernatant remains
• Re-suspend the pellet in 100 µL of supernatant
• Spread on LB agar plate with beads.
• Incubation at 37oC for 24–48 hours.
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A.1.7 Colony PCR and Mini-prep Protocol
Table A.4 : Colony PCR
Positive colonies are taken from the previously streaked plate and inoculated into 5 mL
of LB broth. Overnight incubation was performed at 37oC shaker. The 5 mL of cultures
were centrifuged for 5’ at the top speed. The supernatants were discarded and QIAGEN-
Plasmid DNA Purification Kit was performed on pellets.
QIAGEN - Plasmid DNA Purification Kit Protocol:
1. Re-suspend pelleted bacterial cells in 250 µl Buffer P1 and transfer to a 1.7ml
micro-centrifuge tube. No cell clumps should be visible after resuspension of the
pellet. The bacteria should be resuspended completely by vortexing or pipetting up
and down until no cell clumps remain.
2. Add 250 µl Buffer P2 and mix thoroughly by inverting the tube 4–6 times. Do not
vortex, as this will result in shearing of genomic DNA. If necessary, continue invert-
ing the tube until the solution becomes viscous and slightly clear. Do not allow the
lysis reaction to proceed for more than 5 min. If LyseBlue has been added to Buffer
P1, the cell suspension will turn blue after addition of Buffer P2. Mixing should
result in a homogeneously colored suspension. If the suspension contains localized
colorless regions or if brownish cell clumps are still visible, continue mixing the
solution until a homogeneously colored suspension is achieved.
3. Add 350 µl Buffer N3; mix immediately and thoroughly by inverting the tube 4–6
times. Keep on ice for 10 mins. To avoid localized precipitation, mix the solution
thoroughly, immediately after addition of Buffer N3. The solution should become
cloudy. If LyseBlue reagent has been used, the suspension should be mixed until
all trace of blue has gone and the suspension is colorless.
4. Centrifuge for 10 min at 13,000 rpm ( 17,900 x g) in a table-top micro-centrifuge.
A compact white pellet will form.
5. Apply the supernatants from step 4 to the QIAprep spin column by decanting or
pipetting.
6. Centrifuge for 30 – 60 sec. Discard the flow-through.
7. Wash QIAprep spin column by adding 0.75 ml Buffer PE and centrifuging for 30 –
60 sec.
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8. Discard the flow-through, and centrifuge for an additional 1 min to remove residual
wash buffer.
Important: Residual wash buffer will not be completely removed unless the flow-
through is discarded before this additional centrifugation. Residual ethanol from
Buffer PE may inhibit subsequent enzymatic reactions.
9. Place the QIAprep column in a clean 1.5 ml micro-centrifuge tube. To elute DNA,
add 50 µl Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the center of each QIAprep
spin column, let stand for 1 min, and centrifuge for 1 min.
A.1.8 Expression
• Take positive clones from each transformation plates (Shuffle) by tips.
• Add them to 5 ml LB Broth with 5 µl Ampicillin (1000X)
• After overnight growth at 37oC, take glycerol stocks of each cell culture (200 µl
60% Glycerol + 600 µl cell culture)
• Transfer cell cultures to 30 ml LB Broth with 30 µl Ampicillin (1000X)
• Take 1 ml sample from each of the cultures and label them as t0
• Add IPTG when efficient optimal density is reached.
• For expression of the proteins wait for 8 hours.
• Centrifuge samples for 15 minutes at 4000 rpm.
• Add sufficient amount of B-PER according to the pellet amount (between 100 µl
-250 µl)
• Centrifuge samples for 5 minutes at 13.2 rpm.
• Take 20 µl sample from supernatant and mix with 4 µl dye mix (loading dye +
DTT )
• Load the samples and run SDS-PAGE electrophoresis and carry out the characteri-
zation step.
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A.2 Multiple Sequence Alignments
Figure A.2: The scheme of multiple sequence alignments of the clones against native
ANL.
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Figure A.3: Clone A1
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Figure A.4: Clone A2
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Figure A.5: Clone A3
61
Figure A.6: Clone A4
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Figure A.7: Clone A5
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Figure A.8: Clone A6
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Figure A.9: Clone A7
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Figure A.10: Clone A8
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Figure A.11: Clone A9
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Figure A.12: Clone A10
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Figure A.13: Clone A11
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Figure A.14: Clone A12
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Figure A.15: Clone A13
71
Figure A.16: Clone A14
72
Figure A.17: Clone A16
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Figure A.18: Clone A17
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Figure A.19: Clone A18
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Figure A.20: Clone A19
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Figure A.21: Clone A20
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Figure A.22: Clone A21
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Figure A.23: Clone A22
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Figure A.24: Clone A23
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Figure A.25: Clone A25
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Figure A.26: Clone A26
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Figure A.27: Clone A27
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Figure A.28: Clone A28
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Figure A.29: Clone A30
85
Figure A.30: Clone A32
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Figure A.31: Clone A33
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Figure A.32: Clone A34
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Figure A.33: Clone A35
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Figure A.34: Clone A37
90
Figure A.35: Clone B1
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Figure A.36: Clone B2
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Figure A.37: Clone B6
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Figure A.38: Clone B7
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Figure A.39: Clone B8
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Figure A.40: Clone B9
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Figure A.41: Clone B14
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Figure A.42: Clone B15
98
Figure A.43: Clone B17
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Figure A.44: Clone C2
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Figure A.45: Clone C3
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Figure A.46: Clone C5
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Figure A.47: Clone C6
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Figure A.48: Clone C7
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Figure A.49: Clone C8
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Figure A.50: Clone C9
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Figure A.51: Clone C12
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Figure A.52: Clone C13
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Figure A.53: Clone C14
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Figure A.54: Clone C15
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Figure A.55: Clone C16
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Figure A.56: Clone C18
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Figure A.57: Clone C20
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